Xuchao Zhang Selected Research

Xuchao Zhang Research Topics

Disease

22	Neoplasms (Cancer) 10/2023 - 01/2010
12	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2020 - 07/2009
5	Lung Neoplasms (Lung Cancer) 01/2023 - 07/2010
4	Neoplasm Metastasis (Metastasis) 10/2023 - 11/2016
3	Breast Neoplasms (Breast Cancer) 01/2021 - 01/2019
3	Adenocarcinoma of Lung 01/2020 - 01/2017
3	Hepatocellular Carcinoma (Hepatoma) 01/2020 - 01/2010
2	Carcinoma (Carcinomatosis) 01/2020 - 01/2019
2	Stomach Neoplasms (Stomach Cancer) 01/2020 - 01/2019
2	Pancreatic Neoplasms (Pancreatic Cancer) 01/2019 - 02/2015
2	Asthma (Bronchial Asthma) 03/2014 - 02/2011
2	Lymphoma (Lymphomas) 01/2012 - 07/2010
1	Genetic Translocation (Chromosomal Translocation) 01/2021
1	Glioblastoma (Glioblastoma Multiforme) 01/2021
1	Disease Progression 01/2020
1	Adenocarcinoma 01/2020
1	Hematologic Neoplasms (Hematological Malignancy) 01/2019
1	Mesothelioma 01/2019
1	Neoplasm Micrometastasis 01/2016
1	Esophageal Neoplasms (Esophageal Cancer) 01/2013
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2012
1	Interstitial Lung Diseases (Interstitial Lung Disease) 01/2012
1	Inflammation (Inflammations) 02/2011
1	Nasopharyngeal Carcinoma 01/2010
1	Ataxia Telangiectasia (Louis Bar Syndrome) 01/2010

Drug/Important Bio-Agent (IBA)

8	ErbB Receptors (EGF Receptor)IBA 04/2019 - 07/2009
6	Proteins (Proteins, Gene)FDA Link 10/2023 - 07/2009
4	Chimeric Antigen ReceptorsIBA 01/2020 - 01/2017
4	Tyrosine Kinase InhibitorsIBA 12/2017 - 07/2009
4	Biomarkers (Surrogate Marker)IBA 05/2015 - 07/2009
2	CytokinesIBA 01/2020 - 01/2019
2	MesothelinIBA 01/2020 - 01/2019
2	Gefitinib (Iressa)FDA Link 04/2019 - 01/2017
2	Anaplastic Lymphoma KinaseIBA 01/2016 - 07/2010
2	MicroRNAs (MicroRNA)IBA 02/2015 - 01/2013
2	OzoneIBA 03/2014 - 02/2011
2	DNA (Deoxyribonucleic Acid)IBA 10/2011 - 09/2010
2	Messenger RNA (mRNA)IBA 07/2010 - 01/2010
1	Sucrose (Saccharose)IBA 10/2023
1	Imatinib Mesylate (Gleevec)FDA Link 01/2022
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2021
1	Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA 01/2021
1	ChemokinesIBA 01/2021
1	anlotinibIBA 01/2021
1	Coloring Agents (Dyes)IBA 10/2020
1	N-acetyltalosaminuronic acid (NAT)IBA 10/2020
1	sintilimabIBA 01/2020
1	Programmed Cell Death 1 ReceptorIBA 01/2020
1	Bevacizumab (Avastin)FDA Link 01/2020
1	Tumor Biomarkers (Tumor Markers)IBA 02/2019
1	Granzymes (Granzyme)IBA 01/2019
1	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 01/2019
1	Interleukin-2 (IL2)IBA 01/2019
1	AntibodiesIBA 11/2018
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 01/2017
1	Mucin-1 (CA 15-3 Antigen)IBA 01/2017
1	Indicators and Reagents (Reagents)IBA 01/2017
1	Insulin (Novolin)FDA Link 01/2017
1	Insulin-Like Growth Factor I (IGF-1)IBA 01/2017
1	AntigensIBA 01/2017
1	Interleukin-15 (Interleukin 15)IBA 01/2017
1	Hepatitis B Surface Antigens (HBsAg)FDA Link 01/2016
1	Conditioned Culture MediaIBA 03/2014
1	Interleukin-8 (Interleukin 8)IBA 03/2014
1	Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA 01/2012
1	Cysteine (L-Cysteine)FDA Link 01/2012
1	130-nm albumin-bound paclitaxelIBA 01/2012
1	Paclitaxel (Taxol)FDA LinkGeneric 01/2012
1	Phosphotransferases (Kinase)IBA 01/2012
1	Caveolin 1IBA 01/2012
1	Docetaxel (Taxotere)FDA Link 09/2011
1	Sunitinib (Sutent)FDA Link 09/2011
1	Environmental Pollutants (Pollutants, Environmental)IBA 02/2011
1	GenisteinIBA 01/2010

Therapy/Procedure

8	Therapeutics 01/2023 - 07/2009
4	Immunotherapy 01/2020 - 01/2017
3	Neoadjuvant Therapy 01/2021 - 05/2015
2	Lasers (Laser) 01/2021 - 04/2019
1	Drug Therapy (Chemotherapy) 01/2020
1	Radiotherapy 01/2020
1	Precision Medicine 02/2019
1	Aftercare (After-Treatment) 01/2012